Wall Street Forecasts 42.31% Upside To Terns Pharmaceuticals, Inc. (TERN)

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is among the 14 best booming stocks to buy right now. On January 8, Truist Financial analyst Srikripa Devarakonda reiterated a Buy rating on the stock with a share price target of $56. Wall Street Forecasts 42.31% Upside To Terns Pharmaceuticals, Inc. (TERN) This update is a reaffirmation of the firm’s revision on the stock on December 9, when it lifted the price target to $56 from $35 after the company shared encouraging data from the Phase 1 study of TERN-701, ...